Prelude Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Prelude Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$396K	Buy
2023 Q1	–	Sell
2022 Q4	$90.4K	Buy
2022 Q3	$49K	Sell
2022 Q2	$73K	Buy